Mass. Pharmacies Now Under Greater Scrutiny

Law360, New York (December 10, 2012, 11:34 AM EST) -- The Massachusetts Board of Pharmacy (BOP) enacted emergency regulations effective Nov. 1, 2012, in response to the deadly fungal meningitis outbreak caused by drug contamination at a Massachusetts compounding pharmacy.[1] Most significantly, the regulations require pharmacies to report extensive data to the BOP regarding their compounding activities.

In addition, the regulations implemented new reporting obligations that would affect all registered pharmacies and pharmacists in the state and granted the BOP greater authority to quickly shut down pharmacies and quarantine products in the event of immediate public...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.